Aurobindo Pharma, Dr Reddy's Labs and 4 others partner with Telangana to set up facilities in Pharma City

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-11-27 10:59 GMT   |   Update On 2024-11-27 10:59 GMT
Advertisement

New Delhi: Dr Reddy's LaboratoriesAurobindo Pharma, and Hetero Labs and 3 other pharmaceutical companies have signed memorandums of understanding (MoUs) with the Telangana government for setting up facilities in the Pharma City with an investment of over Rs 5,260 crore, the government announced on Friday. 

The investment is expected to create 12,490 job opportunities in the pharma sector, according to an official release.

Advertisement

"The pharma company managements signed MoUs to establish the industries. The six companies expressed their interest to invest more than Rs 5260 crore. The investments will provide 12,490 job opportunities in the pharma sector. The government will allocate land for the establishment of the new pharma manufacturing units in the recognised pharma city," the release said.

According to PTI, representatives from the companies met with Chief Minister A Revanth Reddy and Industries Minister D Sridhar Babu at the Secretariat to finalise the agreements.
According to the MoUs, MSN Laboratories will establish a manufacturing unit and an R&D center, Laurus Labs and Aurobindo Pharma will set up separate formulation units, and Gland Pharma will open an R&D center along with injectables and drug substance manufacturing units.
Dr Reddy's Labs will build an injectable and biosimilars unit, while Hetero Labs will establish a finished dose and injectable manufacturing plant, the release added.
The Chief Minister instructed officials to allocate land for the new facilities and ensure the necessary infrastructure is provided in the Pharma City, with construction work to begin within the next four months

Read also: Aurobindo Pharma Partners with Global Pharma Major for Respiratory Product Development

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News